Beyond staging: Potentially divergent trajectories of pain, quality of life, and fertility in endometriosis - prospective observational cohort study.

This prospective cohort study reveals that endometriosis comprises partially independent dimensions where pain severity and quality of life are driven by neuroinflammatory mechanisms rather than anatomical staging, while fertility outcomes and organ-threatening complications are primarily determined by structural disease burden.

The Gist

Imagine your body as a bustling city. In this city, Endometriosis is like a rebellious construction crew that keeps building illegal structures (lesions) in places they shouldn't be, like the streets, parks, and utility lines.

For decades, doctors have tried to measure how "bad" this rebellion is by simply counting the number of illegal buildings. They have maps (staging systems like r-ASRM and Enzian) that tell them: "Oh, this patient has a small shack here and a warehouse there, so they are Stage 2. This patient has a whole factory complex, so they are Stage 4."

The old assumption was: More buildings = More pain.

But this new study, conducted by researchers in Prague, says: "Not so fast."

They followed 145 women over a year and discovered that the city of Endometriosis actually runs on two completely different operating systems that don't always talk to each other.

The Two Operating Systems

1. The "Neuro-Inflammatory" System (The Pain & Mood Engine)

Think of this as the city's alarm system and mood ring.

• What it does: It controls how much pain you feel and how miserable your daily life is.
• The Surprise: The researchers found that the size of the illegal buildings has almost nothing to do with how loud the alarm rings.
  • A woman with a tiny, hidden "shack" (minimal disease) might be screaming in agony because her alarm system is hypersensitive.
  • A woman with a massive "factory" (severe disease) might feel relatively fine because her alarm system is quiet.
• The Secret Code: When they looked at the "wiring" inside the painful lesions (using RNA sequencing), they found a specific chemical signature. It was like finding a "High Alert" signal. The tissue was flooded with inflammatory chemicals (like IL6) and had activated its own pain-control switches (endocannabinoids), trying desperately to calm itself down but failing.
• The Takeaway: Pain is driven by chemistry and nerves, not just by how many buildings are there.

2. The "Structural" System (The Fertility & Plumbing Engine)

Think of this as the city's physical infrastructure and plumbing.

• What it does: It controls whether you can get pregnant and if your vital organs (like the kidneys) are in danger.
• The Reality: This system does care about the size and location of the buildings.
  • If the illegal construction crew builds a wall across the "fertilization highway" (fallopian tubes) or crushes the "water pipes" (ureters), you will have trouble getting pregnant or risk kidney failure.
  • Interestingly, pain levels didn't predict this. A woman could be in zero pain but still have her plumbing crushed by a large, silent tumor.
• The Takeaway: Fertility and organ safety are driven by physical blockage and scarring, not by how much it hurts.

The Creative Analogy: The "Silent House" vs. The "Noisy Tent"

To make this even clearer, imagine two houses:

• House A (The Silent House): It has a massive, collapsing roof and a foundation cracking the whole street (Severe Endometriosis). But the owner is wearing noise-canceling headphones and feels fine. They can't get pregnant because the house is structurally unsound, but they aren't in pain.
• House B (The Noisy Tent): It's just a small, flimsy tent in the backyard (Mild Endometriosis). But the wind is howling through a tiny hole, and the owner is terrified, in constant pain, and can't sleep or work. The structure is fine, but the experience is terrible.

The study proves that you cannot judge the structural safety of the house by how noisy the owner is, and you cannot judge the owner's pain by how big the house is.

What This Means for Patients and Doctors

1. Stop Guessing: Doctors can no longer look at a scan, see a small spot, and say, "Don't worry, you won't have much pain." Or look at a huge mass and say, "You're lucky, you don't have pain." The two things are independent.
2. Treat the Pain Differently: Since pain is driven by a "neuro-inflammatory" chemical storm, just cutting out the tissue might not stop the pain if the alarm system is still broken. Patients with severe pain might need medicines that calm the nerves (like gabapentin) or reduce inflammation, rather than just surgery.
3. Watch the Plumbing: Even if a patient says, "I feel fine," doctors must still check the "plumbing" (ureters and tubes) because the structural damage can happen silently.
4. Fertility is Structural: If a woman wants to get pregnant, the focus should be on clearing the physical obstacles (the "buildings"), not just on managing the pain.

The Bottom Line

Endometriosis isn't just one disease; it's two different problems happening at the same time.

• Problem A: A chemical storm causing pain and misery (unrelated to size).
• Problem B: A physical blockage causing infertility and organ damage (related to size).

To treat a patient effectively, doctors need to check both the chemical storm and the physical blockage, rather than just counting the buildings. This study gives us the map to finally treat the whole person, not just the lesions.

Technical Summary

1. Problem Statement

Endometriosis is a heterogeneous, chronic inflammatory disease affecting 10–15% of reproductive-age women. A longstanding clinical challenge is the poor correlation between anatomical disease burden (lesion size and location) and symptom severity (pain) or reproductive outcomes.

• Current staging systems (r-ASRM, Enzian) effectively map anatomical extent but fail to predict pain intensity or quality-of-life (QoL) impairment.
• Conversely, fertility outcomes appear linked to structural distortion but not necessarily to pain levels.
• There is a lack of integrated models that simultaneously analyze anatomical staging, multidimensional symptom profiles, molecular signatures, and longitudinal reproductive outcomes across different endometriosis subtypes (Ovarian, Deep, and Peritoneal).

2. Methodology

Study Design:

• Type: Prospective observational cohort study with longitudinal follow-up.
• Setting: Tertiary endometriosis center at General University Hospital in Prague (2023–2025).
• Participants: 145 women aged 18–45.
  • Endometriosis Groups: Ovarian Endometriosis (OE, n=33), Deep Endometriosis (DE, n=55), Peritoneal Endometriosis (PE, n=25).
  • Control Group: Healthy controls undergoing benign laparoscopic/hysteroscopic procedures (n=32).
• Inclusion: Laparoscopic and histologically confirmed diagnosis; complete baseline data.

Data Collection & Assessment:

• Anatomical Staging: Assessed via r-ASRM (I–IV) and Enzian classification (both preoperative ultrasound [u] and intraoperative surgical [s]).
• Symptom Assessment: 11-point Numeric Rating Scale (NRS) for chronic pelvic pain, dysmenorrhea, dyspareunia, dysuria, and dyschezia. A composite pain score was calculated.
• Quality of Life: Measured using the Endometriosis Health Profile (EHP-30+23) across four domains: physical/functional, symptom burden/control, emotional distress, and social identity/stigma.
• Reproductive Outcomes: Sterility status (failure to conceive after ≥12 months), pregnancy rates (spontaneous and ART) at 12-month follow-up, and Anti-Müllerian Hormone (AMH) levels.
• Molecular Analysis: A subset of lesion samples underwent RNA sequencing (RNA-seq). Patients were stratified into "High-Pain" (composite score >15.5) and "Low-Pain" groups to identify pain-associated molecular signatures.

Statistical Analysis:

• Non-parametric tests (Kruskal–Wallis, Dunn's test) for group comparisons.
• Spearman correlation coefficients for relationships between pain, staging, and QoL.
• Differential gene expression analysis using DESeq2 (Benjamini-Hochberg correction).

3. Key Contributions

This study provides a multidimensional framework for understanding endometriosis, proposing that the disease operates along two partially independent biological axes:

1. A Neuroinflammatory Axis: Governs pain severity and QoL impairment, driven by molecular mechanisms rather than lesion size.
2. A Structural/Fibrotic Axis: Governs fertility outcomes, surgical complexity, and organ-threatening complications (e.g., ureteral obstruction), driven by anatomical distortion.

4. Key Results

A. Pain vs. Anatomy (The Dissociation)

• Weak Correlation: Pain severity showed limited to no correlation with anatomical staging (r-ASRM or Enzian scores) in OE and DE subtypes.
• Subtype Specificity:
  • PE: Showed some correlation between pain and Enzian compartments A/B.
  • OE & DE: High anatomical burden did not correspond to proportional increases in pain.
• Pain Architecture: PE exhibited a globally coherent pain phenotype (strong correlations across all pain domains), whereas OE and DE showed more compartmentalized or weak inter-domain correlations.

B. Quality of Life (QoL)

• QoL impairment closely paralleled pain intensity rather than anatomical stage.
• DE and PE patients reported significantly worse QoL across all domains compared to controls; OE patients showed modest impairment.
• In DE and PE, QoL was strongly correlated with dysmenorrhea, pelvic pain, and dyschezia.

C. Molecular Signatures of Pain

• Transcriptomic analysis of high-pain vs. low-pain lesions revealed a distinct molecular program associated with severe pain, independent of subtype:
  • Inflammatory Mediators: Upregulation of IL6, OSM, CCL8, SPP1 (cytokine-driven nociceptor sensitization).
  • Nociceptive Transcription Factors: Elevated NR4A3 and EGR3 (indicating neuronal sensitization).
  • Endocannabinoid System: Upregulation of PENK (proenkephalin) and CNR1 (cannabinoid receptor 1), suggesting a compensatory neuroregulatory response to chronic pain.

D. Fertility and Structural Burden

• Infertility Drivers: Infertility was strongly associated with structural disease burden (higher Enzian scores, advanced r-ASRM stage in PE) and not with pain severity.
• Sterility: Women with confirmed infertility had higher laparoscopic Enzian scores (significant in DE) but similar pain scores to fertile women.
• Post-Surgical Outcomes: While pain and QoL improved significantly post-surgery across all stages, pregnancy rates at 12 months did not significantly improve and were not predicted by pain reduction. In DE, pregnancy was associated with lower residual Enzian scores and improved QoL.

E. Ureteral Surgery Predictors

• The need for ureter surgery was strongly predicted by anatomical extent (laparoscopic Enzian scores, tubal involvement, compartment B lesions).
• Symptom severity (dyschezia, dyspareunia) showed negative but non-significant associations, highlighting that organ-threatening complications can occur without severe pain.

5. Significance and Clinical Implications

Paradigm Shift:
The study challenges the "lesion-based continuum" model of endometriosis. It argues that pain/QoL and fertility/structural risk are distinct clinical dimensions requiring different management strategies.

Clinical Management:

• Symptom Assessment: Anatomical staging alone cannot estimate symptom burden. Routine integration of validated patient-reported outcome measures (PROMs) is essential.
• Therapeutic Targeting:
  • For Pain: Standard anti-inflammatories (NSAIDs) may be insufficient for patients driven by cytokine-mediated sensitization. The study suggests neuromodulatory agents (gabapentinoids, SNRIs) targeting the identified neuroimmune pathways (IL6, NR4A3, endocannabinoid system).
  • For Fertility/Structure: Management must prioritize anatomical assessment (Enzian staging) to prevent organ compromise (e.g., ureteral obstruction) and address structural infertility, regardless of pain levels.

Future Directions:
The findings advocate for integrated phenotyping combining anatomical staging, symptom profiling, and molecular biomarkers to enable personalized treatment plans that address both the neuroinflammatory and fibrotic axes of the disease.

Limitations:

• Transcriptomic analysis was limited to a subset of samples.
• Pain assessment relies on self-reporting.
• Observational design limits causal inference regarding mechanistic pathways.
• The study is a preprint and has not yet undergone peer review.